NCT07233798

Brief Summary

Lumbar spinal stenosis is defined as the narrowing of the spinal canal resulting from degenerative changes in the spinal joints, intervertebral discs, and the ligamentum flavum. Pressure fluctuations within the cerebral and spinal vascular systems lead to the formation of pulsations. The periodic occurrence of these pulsations in the dura mater is referred to as spinal dural pulsation.The vibratory movements of the dura mater have been interpreted as an indicator that the spinal cord is freely mobile within the subarachnoid space and not subjected to any external compression.This study aims to investigate whether the presence of dural pulsation is associated with clinical and radiological parameters in patients diagnosed with lumbar spinal stenosis

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Dec 2025Dec 2026

First Submitted

Initial submission to the registry

July 1, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 18, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

December 7, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2026

Expected
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

July 1, 2025

Last Update Submit

March 9, 2026

Conditions

Keywords

Dural Pulsationoswestry disability index

Outcome Measures

Primary Outcomes (4)

  • The Numeric Rating Scale (NRS)

    The Numeric Rating Scale (NRS) is a unidimensional, self-reported measure of pain intensity that is widely used in both clinical practice and research, including studies involving patients with chronic pain. On this scale, patients rate their current level of pain on an 11-point numeric range from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain imaginable." Higher scores indicate greater pain intensity.

    At the time of data collection

  • Oswestry Disability Index

    The Oswestry Disability Index (ODI) is a widely used and validated questionnaire designed to assess the degree of disability and functional impairment in patients with low back pain. It evaluates the impact of pain on various aspects of daily living and physical function through ten sections, each scored from 0 to 5, with higher scores indicating greater disability. The total score is converted into a percentage by dividing the obtained score by the maximum possible score and multiplying by 100, yielding a final score ranging from 0% (no disability) to 100% (maximum disability).

    At the time of data collection

  • SHORT FORM-12

    The Short Form-12 (SF-12) is a health-related quality of life assessment tool that summarizes an individual's physical and mental health status through 12 items. It is a shortened version of the SF-36 questionnaire and measures eight health domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. The SF-12 produces two composite scores - the Physical Component Summary (PCS) and the Mental Component Summary (MCS) - which are standardized to a mean of 50 and a standard deviation of 10 in the general population. Higher scores indicate better health status and quality of life.

    At the time of data collection

  • Walking Distance Capacity

    At the time of data collection

Secondary Outcomes (3)

  • Dural anteroposterior diameter measured by MRI at the stenotic level

    At the time of data collection

  • Dural cross-sectional area measured by MRI at the stenotic level

    At the time of data collection

  • Schizas classification of the stenotic level on MRI

    At the time of data collection

Study Arms (2)

Positive for dural pulsation

Negative for dural pulsation

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients aged between 18 and 85 years diagnosed with lumbar spinal stenosis based on physical examination, clinical evaluation, and lumbar magnetic resonance imaging.

You may qualify if:

  • Aged between 18 and 85 years
  • Patients experiencing low back and/or leg pain attributable to lumbar spinal stenosis
  • Presence of lumbar spinal stenosis at least at one level consistent with clinical symptoms on lumbar MRI

You may not qualify if:

  • Body Mass Index (BMI) ≥ 35 kg/m²
  • Patients with radiculopathy due to lumbar disc herniation
  • Patients with axial low back pain caused by facet syndrome, sacroiliac dysfunction, or discogenic pain
  • History of lumbar spine surgery
  • Individuals with mental retardation
  • Patients with major psychiatric comorbidities
  • Patients with congenital spinal anomalies
  • Inflammatory rheumatic diseases characterized by osteophyte formation and ligament calcification, such as ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis (DISH)
  • Pregnancy
  • Patients with heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Faculty of Medicine, Pendik Training and Research Hospital, Algology Department

Pendik, Istanbul, 34890, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Spinal StenosisIntermittent Claudication

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesPeripheral Arterial DiseasePeripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Fatma B Akdağ, Research Assistant

    Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation

    PRINCIPAL INVESTIGATOR
  • Osman H Gündüz, Professor

    Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine

    STUDY DIRECTOR
  • Serdar Kokar, Associate Professor

    Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine

    STUDY DIRECTOR
  • Savaş Şencan, Associate Professor

    Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine

    STUDY DIRECTOR

Central Study Contacts

Fatma B Akdağ, Research Assistant

CONTACT

Savaş Şencan, Associate Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2025

First Posted

November 18, 2025

Study Start

December 7, 2025

Primary Completion (Estimated)

December 20, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations